Search

everythinglearnresearchcommunity

for

Search:↓

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

EPDS and MS might share an immune-related cause.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Certain drugs that block specific enzymes can help treat prostate diseases.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Start acne treatment early to prevent scarring, consider antibiotic resistance, use maintenance therapy, and manage side effects carefully.

Acne in children varies by age and severity, requires a pediatric treatment approach, and may need diagnostic evaluation for underlying conditions.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Pregnancy can cause various skin changes, including pigmentation, acne, and stretch marks, and may affect preexisting skin conditions.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Alopecia areata treatment varies, with no optimal method established yet.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.